TLIS Talis Biomedical Company Net Income

Official company branding of Talis Biomedical (TLIS)

Talis Biomedical's development of rapid tests promotes environmental sustainability by reducing patient logistics. The recognition of the Talis One platform for its accuracy in diagnosing respiratory pathologies is confirmed by the company's profit dynamics, which the base chart on GURU.Markets contains, while -0.05 sets the current value of the indicator. Meanwhile, the market has already priced in the costs of internal restructuring and the formation of liquidity reserves.

TLIS talis.bio Net Income (07/04/2022 - 09/07/2024)

Financial and market metric breakdowns for talis.bio (TLIS)

- stock quotes and analyst forecast:
Share Price Talis Biomedical Corporation|TLIS - Price Target Chart
- market capitalization data:
Market Value Talis Biomedical Corporation|TLIS - Total Company Value
- balance sheet equity data:
Net Assets per Share Talis Biomedical|TLIS - Company Net Assets|Market Cap to Book Value Multiple talis.bio|TLIS - Company Total Assets
- debt and liquidity details:
Total Debt to Capital Coefficient Talis Biomedical|TLIS - Long-Term Debt to Capital|Short-Term Debt to Equity Ratio Talis Biomedical Corporation|TLIS - Company Total Debt|Debt to Net Assets Ratio Talis Biomedical Corporation|TLIS - Company Long-Term Debt|Company Current Liabilities Talis Biomedical|Immediate Liquidity talis.bio
- earnings and multiples data:
TLIS - Net Profit
Summary company analysis:Talis Biomedical Corp (TLIS)
Mass-produced product of Talis Biomedical Corp.

Talis Biomedical (TLIS) is in a state of deep decline, having moved toward asset liquidation following the commercial failure of the Talis One platform. The daily calculation of financial results strips the business value of market noise, allowing the tracking of actual cash inflows through the company's real profits and the timely identification of risks regarding a total capital freeze in a stagnating enterprise.

Main competitors

Company Profit ABT|Company Net Income Thermo Fisher Scientific|Company Net Income gehealthcare.com GEHC|Company Net Income Mettler Toledo (MTD)|Net Financial Result Waters Corp|Techne Corporation - Net Income|Profit After Payment of Taxes BRKR (Bruker BioSpin)|Azenta, Inc. - Net Profit|Net Financial Result vareximaging.com VREX|SMLR: Net Profit|Net Income Butterfly Network Inc|Net Income MLAB|QSI: Final Profit|Company Net Income Nano-X Imaging Ltd. (NNOX)|Net Income quanterix.com QTRX|Net Profit MASS (908 Devices)|CapsoVision, Inc. (CV) - Company Net Income|MaxCyte, Inc - Net Profit|RPID (Rapid Micro Biosystems) - Company Profit|SEER: Net Profit|HYPR - Net Financial Result|FONR (FONAR) - Net Profit|Net Income Daxor Corp. (DXR)|Net Profit MDAI|Net Profit VivoSim Labs (VIVS)|Company Net Income Aclarion ACON|Akoya Biosciences Inc - Company Net Income|THMO: Net Income|Final Profit TTOO (T2 Biosystems Inc.)